<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01043679</url>
  </required_header>
  <id_info>
    <org_study_id>01122009/S09070</org_study_id>
    <nct_id>NCT01043679</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania</brief_title>
  <acronym>UtapMani</acronym>
  <official_title>A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research is to evaluate the safety as well as effectiveness of Utapine and
      Seroquel in bipolar I disorder patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Utapine and Serquel belong to anti-bipolar medication family, both are approved by DOH
      (Department of Health, Taiwan), both has same ingredient but different manufacture. From
      clinical trial reports, both has excellent effectiveness and safety. The goal of this
      research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in
      bipolar I disorder patients for different ingredient and different manufacture.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bipolar, Mania</condition>
  <condition>Utapine</condition>
  <condition>Seroquel</condition>
  <arm_group>
    <arm_group_label>Seroquel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Efficacy and Safety of Seroquel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Utapine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Efficacy and Safety of Utapine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Utapine</intervention_name>
    <description>Efficacy and Safety of Utapine</description>
    <arm_group_label>Utapine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Seroquel</intervention_name>
    <description>Efficacy and Safety of Seroquel</description>
    <arm_group_label>Seroquel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female age 18-65 years with diagnosis of bipolar I disorder who will be
             included by DSM-IV criteria made at least one manic or mixepisode record before study
             entry.

          2. Having a minimum score of 20 on the Young Mania Rating Scale (YMRS), plus a score of
             at least 4 on two of the core YMRS items of Irritability,Speech, Content, and
             Disruptive/Aggressive Behavior.

          3. At least 4 will be on the Severity of Illness item of the Clinical Global
             ImpressionsNBipolar(CGINBP)assessment tool.

          4. Patient with good compliance to study medicine and adherence to study protocol.

        Exclusion Criteria:

          1. Had received treatment with clozapine within 28 days of the start of the trial.

          2. Had been hospitalised for 3 weeks or longer for the index manic episode.

          3. DSM-IV criteria for rapid cycling or a current mixed episode.

          4. Intolerance or lack of response to quetiapine or clozapine before this trial be
             diagnosed by investigator.

          5. Neurodegenerative disease eg:Parkinson desease、Huntington disease、Pick's disease.

          6. Medicine or drugs which can change mental condition be judged by investigator.

          7. EKG abnormality

          8. Drug or alcohol abuser
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chin-Hong Chan, MD.,MS.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chin-Hong Chan, MD., MS.</last_name>
    <phone>886-4-23592525</phone>
    <phone_ext>3407</phone_ext>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tsuo-Hung Lan, MD.,PhD.</last_name>
    <phone>886-4-23592525</phone>
    <phone_ext>3460</phone_ext>
    <email>tosafish@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung City</city>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chin-Hong Chan, MD., MS.</last_name>
      <phone>886-4-23592525</phone>
      <phone_ext>3407</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Tso-Hung Lan, MD.,PhD.</last_name>
      <phone>886-4-23592525</phone>
      <phone_ext>3460</phone_ext>
      <email>tosafish@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2010</study_first_submitted>
  <study_first_submitted_qc>January 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2010</study_first_posted>
  <last_update_submitted>January 14, 2010</last_update_submitted>
  <last_update_submitted_qc>January 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>IRB TCVGH</name_title>
    <organization>Taichung Veterans General Hospital</organization>
  </responsible_party>
  <keyword>Bipolar, Mania</keyword>
  <keyword>Utapine</keyword>
  <keyword>Seroquel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetiapine Fumarate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

